Nasal Drug Delivery Technology Market – Trends Forecast Till 2028

Nasal Drug Delivery Technology Market by Dosage Form (Nasal Drops, Sprays, Powder, Gel), System (Multidose, Unit Dose, BI-Dose), Therapeutic Applications (Rhinitis, Congestion, Vaccinations), End-User (Hospitals, Homecare) and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa and South America)

Published Date: May, 2021

Base Year Estimate: 2020

Report ID: D-PH-NDDTM-162

Format:  

Number of Pages: 376

Domain: Pharmaceutical

Nasal Drug Delivery Technology Market – Trends Forecast Till 2028

The global nasal drug delivery technology market is projected to reach USD 64.20 billion by 2021, at a CAGR of 6.5% during the forecast period.

Increasing patient preference for nasal drug delivery as a result of easy administration & better efficacy and growing adoption of self-administration practices are some of the factors that have supported long-term expansion for the nasal drug delivery industry.

Nasal Drug Delivery Technology Market Report 

Nasal Drug Delivery Technology Market is segmented into dosage form, containers, systems, therapeutic application, end-user, and geography.

Dosage form segment is segmented into Nasal Spray, Nasal Drops and Liquids, Nasal Gels, and Nasal Powders.

The container segment is segmented into Non-Pressurized Containers and Pressurized Containers.

Systems segment is segmented into multi-dose, bi-dose, unit dose.

The therapeutic application segment is segmented into Allergic and Non-Allergic Rhinitis, Nasal Congestion, and Vaccinations.

The end-user segment is segmented into hospitals and home health care.

Geographically, Nasal Drug Delivery Technology Market is sub-segmented into North America, Europe, Asia-Pacific, Middle East, and Africa, and South America and insights are provided for each region and major countries within the regions.

Key players in Nasal Drug Delivery Technology Market are Merck & Co., Inc., Novartis AG, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Pfizer Inc., AstraZeneca PLC, Aptargroup, Inc., Aegis Therapeutics LLC, 3M, Becton, Dickinson, and Company.

Available Customizations

In addition to the market data for Nasal Drug Delivery Technology Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

Research Methodology

Secondary Research

This research method involved the usage of extensive secondary sources (such as directories and databases)—Hoovers, Avention, annual reports, investor presentation, a conference like Jefferies conference)—to identify and collect information useful for this study of the Nasal Drug Delivery Technology Market. During this research study, major players operating in the nasal drug delivery technology market in various regions have been identified, and their offerings, regional presence, and distribution channels have been analyzed through in-depth discussions. Sizes of the other individual markets have been estimated using the percentage splits obtained through secondary sources such as Hoovers, Bloomberg BusinessWeek, and Factiva, along with primary respondents.

Primary Research

The entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews with industry experts such as CEOs, VPs, directors, and marketing executives for key insights (both qualitative and quantitative) on the market

The primary Respondent breakdown is given below:

Nasal Drug Delivery Technology Market Primary Respondents 

 

Market Sizing

Top-down and bottom-up approaches have been used to determine the overall market size

Data Validation

Impact analysis has been conducted for deriving the market size. After collecting the in-depth quantitative and qualitative data we contact the primary respondent to gain a 98.8% of confidence level on our data.

The data validation involves the primary research from the industry experts belonging to:

  • Leading Companies
  • Suppliers & Distributors
  • Manufacturers
  • Consumers
  • Industry/Strategic Consultants

Reasons to Acquire

  • Increase your understanding of the market for identifying the best and suitable strategies and decisions based on sales or revenue fluctuations in terms of volume and value, distribution chain analysis, market trends, and factors
  • Gain authentic and granular data access for nasal drug delivery market to understand the trends and the factors involved behind changing market situations
  • Qualitative and quantitative data utilization to discover arrays of future growth from the market trends of leaders to market visionaries and then recognize the significant areas to compete in the future
  • In-depth analysis of the changing trends of the market by visualizing the historic and forecast year growth patterns

Report Scope

 

Report Feature

Descriptions

Market Revenue In 2021

USD 64.20 billion

Growth Rate

CAGR of 6.5% during the forecasting period, 2021-2028

Historical Data

2018-2019

Forecast Years

2021-2028

Base Year

2020

Units Considered

Revenue in USD billion and CAGR from 2021 to 2028

Report Segmentation

Product, Application, End-User, and Geography

Report Attribute

Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling

Regional Level Scope

North America, Europe, Asia-Pacific, South America, and the Middle East and Africa

Country Level Scope

U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe)

Companies Profiled

Merck & Co., Inc., Novartis AG, GlaxoSmithKline PLC, Johnson & Johnson Services, Inc., Pfizer Inc., AstraZeneca PLC, Aptargroup, Inc., Aegis Therapeutics LLC, 3M, Becton, Dickinson and Company

Available Customization

In addition to the market data for Nasal Drug Delivery Technology Market, Delvens offers client-centric reports and customized according to the company’s specific demand and requirement.

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Please complete the form below:

This website is secure and your personal details are safe. Privacy Policy

Choose License Type
Global: 50+ Countries

Note: Report data and information will be by Country.


Regional Report

Note: Report data and information will be by Country.


Country Specific Report

Bundle Reports

50% Discount on all additional reports  

Special Pricing

Avail customised purchase options to meet your specific research requirements.

Custom Tailored Services

Delvens. offers transformed research reports where syndicated reports are not sufficient to provide solutions to your business.

Subscription Model

Get latest and trending updates throughout the year on the reports you buy.